Innovation

Innovation ICN2

March 15, 2022

INBRAIN Neuroelectronics signs an agreement to develop neurotechnology patented by six public research institutions

A technology-based company for the development of graphene-based applications for neurological diseases, and founded by…

Marta Llorens

Love0

Innovation ICN2

July 8, 2021

INBRAIN Neuroelectronics collaborates with Merck to develop the next generation of bioelectronic therapies

The ICN2 and ICREA spin-off INBRAIN Neurolectronics starts a collaboration with the leading biotechnology company…

Jenny Kliver

Love0

Innovation ICFO

May 27, 2021

LuxQuanta becomes ICFO’s 10th spin-off

The BIST centre ICFO has launched a new spin-off company to exploit quantum technologies to…

Jenny Kliver

Love0

Innovation ICIQ

September 7, 2020

Treellum Technologies: Bringing light to labs

Treellum Technologies, the new spin-off created at the Institute of Chemical Research of Catalonia (ICIQ),…

Jenny Kliver

Love0

Innovation IFAE

September 3, 2020

Spin-off Qilimanjaro Quantum Tech pioneers quantum computing in Europe

A team of researchers including Dr. Pol Forn Díaz of the Institute for High Energy…

Jenny Kliver

Love0

Innovation IRB Barcelona

June 17, 2020

Ona Therapeutics, a start-up by IRB Barcelona, raises €30M in Series A financing

• Ona Therapeutics, a spin-off from the BIST centre IRB Barcelona and ICREA, was founded by researchers…

Adela Farré

Love0

Innovation IRB Barcelona

June 4, 2020

IRB Barcelona spin-off Iproteos acquired by Accure Therapeutics

Iproteos, one of the five spin-offs launched by IRB Barcelona, a BIST centre, focuses on…

Jenny Kliver

Love0

Institutional Members of the Board of Trustees

BIST is an institution of scientific cooperation of seven top research centres committed to creating a collaborative environment of multidisciplinary scientific excellence: CRG, IBEC, ICFO, ICIQ, ICN2, IFAE i IRB Barcelona

Monthly newsletter

SUBSCRIBE TO OUR NEWSLETTER

Follow us

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

INBRAIN Neuroelectronics signs an agreement to develop neurotechnology patented by six public research institutions

INBRAIN Neuroelectronics collaborates with Merck to develop the next generation of bioelectronic therapies

LuxQuanta becomes ICFO’s 10th spin-off

Treellum Technologies: Bringing light to labs

Spin-off Qilimanjaro Quantum Tech pioneers quantum computing in Europe

Ona Therapeutics, a start-up by IRB Barcelona, raises €30M in Series A financing

IRB Barcelona spin-off Iproteos acquired by Accure Therapeutics

Cookies Policy – Privacy Policy – Legal Notice – Transparency Policy